Surprising impact of stromal TIL's on immunotherapy efficacy in a real-world lung cancer study.
Hashemi S, Fransen MF, Niemeijer A, Ben Taleb N, Houda I, Veltman J, Becker-Commissaris A, Daniels H, Crombag L, Radonic T, Jongeneel G, Tarasevych S, Looysen E, van Laren M, Tiemessen M, van Diepen V, Maassen-van den Brink K, Thunnissen E, Bahce I.
Hashemi S, et al.
Lung Cancer. 2021 Mar;153:81-89. doi: 10.1016/j.lungcan.2021.01.013. Epub 2021 Jan 14.
Lung Cancer. 2021.
PMID: 33465698
Free article.